Ophthalmology Search
Ophthalmology Ophthalmology
primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.

History

  • Review of history of family, ocular & systemic diseases (eg DM, hypertension, asthma, vascular disorders) are obtained during initial evaluation
  • Current medications (ocular & systemic) being taken & history of adverse reactions to these drugs
  • History of eye surgery
    • Cataract surgery, photorefractive keratectomy may result in a falsely low intraocular pressure (IOP)
  • Ocular trauma (eg contusion)

Physical Examination

Visual Acuity

  • Measure & determine best corrected near & distance visual acuity

Examination of Pupils

  • Examine for reactivity & presence of afferent pupillary defect

Examination of the Fundus

  • Look for cupping, macular degeneration, disc edema, retinovascular occlusion, optic nerve pallor & pits
    • Cupping is the hallowing out of the optic nerve or “disc” & a diameter of >50% of the vertical disc signifies glaucoma

Imaging

Biomicroscopy

  • Assess the anterior chamber depth & angle, look for corneal defects, iris pathology or inflammation using slit-lamp biomicroscope to help determine for presence of a secondary cause of intraocular pressure (IOP) elevation

Tonometry

  • Bilateral measurement of IOP using Goldmann applanation tonometry done at varying times of the day or on different days to detect fluctuations
  • It is recommended to measure untreated IOP more than once prior to starting treatment

Gonioscopy

  • Important to exclude secondary causes of IOP (eg peripheral anterior synechiae, angle neovascularization, angle recession, etc) or exclude diagnosis of angle closure

Examination of Optic Nerve Head & Retinal Nerve Fiber Layer

  • Changes in these structures often precede visual field loss in glaucoma patients
    • Look for changes such as optic disc hemorrhages, peripapillary choroidal atrophy 
  • Performed using magnified stereoscopic visualization, digital photography & stereophotographic techniques w/ red-free illumination

Other Tests

  • Central corneal thickness (CCT) measurement (pachymetry) - helps to determine level of risk for ocular damage
  • Visual Field Test (eg Automated static threshold perimetry, short-wavelength automated perimetry or SWAP, frequency doubling technology or FDT)
  • Optical Coherence Tomography (OCT), Heidelberg Retinal Tomogram (HRT) & scanning laser polarimetry - for early detection of nerve fiber layer thinning
Editor's Recommendations
Most Read Articles
Beta-blockers may reduce mortality in patients with heart failure, renal dysfunction
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
New from USPSTF: Breast cancer risk-reduction recommendations
Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.
UTI risk not raised with SGLT-2is in real-world study
Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
Lower HbA1c prolongs hypoglycaemia duration in type 2 diabetics
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.